PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsGene links cannabis use and mental illness

BioNews

Gene links cannabis use and mental illness

Published 9 June 2009 posted in News and appears in BioNews 304

Author

BioNews

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

A person's risk of developing a psychotic illness such as schizophrenia after smoking cannabis as a teenager is affected by their genetic make-up, say UK researchers. A new study to be published in the journal Biological Psychiatry shows that a variant of the COMT gene is linked to a five-fold...

A person's risk of developing a psychotic illness such as schizophrenia after smoking cannabis as a teenager is affected by their genetic make-up, say UK researchers. A new study to be published in the journal Biological Psychiatry shows that a variant of the COMT (catechol-O-methyl transferase) gene is linked to a five-fold increased risk of psychotic illness in people who have smoked the drug. The scientists, based at the Institute of Psychiatry at King's College London, say that neither cannabis nor the genetic variation alone is enough to trigger psychosis.


The team looked at a group of 803 people born between April 1972 and March 1973 in Dunedin, New Zealand, who have been tracked since birth as part of a long-term health study. According to a report in the Times newspaper, the participants were asked about their cannabis use at the ages of 13, 15 and 18. They were also tested to see what form of the COMT gene they had inherited, since this gene has previously been linked to schizophrenia. This illness is one of several psychotic disorders thought to involve an imbalance in levels of dopamine, a key brain chemical.


The COMT gene comes in two different varieties, known as 'val' and 'met'. In people with two met versions of the gene, the rate of psychotic illness was three per cent, regardless of whether they had smoked cannabis as a teenager or not. But in people with two val versions, the rate was 15 per cent in cannabis smokers, compared to three per cent in non-smokers. The findings suggest that the val gene variant and cannabis both affect the brain's dopamine system, delivering a 'double dose' that can be damaging. The group has previously published research showing that variations in another brain chemical gene affect how well a person copes with stressful life events, and their subsequent risk of depression.


Marjorie Wallace, chief executive of the mental health charity Sane, said that it was becoming clear that cannabis placed millions of users at risk of lasting mental illness. 'If we were able genetically to identify the vulnerable individuals in advance, we would be able to save thousands of minds, if not lives', she said. However, study leader Avshalom Caspi disagreed, saying that 'such a test would be wrong more often than it is right'. He said that since smoking cannabis has 'many other adverse effects', even people who are not genetically vulnerable should not be encouraged to use the drug.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 1 minute read

Genes hint at schizophrenia complexity

by Ailsa Stevens

Three independent studies have identified gene variants which contribute significantly to schizophrenia risk, taking steps towards understanding the cause of this highly complex condition which affects 1 in 100 people. Two of the three gene variants discovered were rare, but conferred 12 and 15 percent higher risks...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 1 minute read

New findings may transform hunt for schizophrenia genes

by Ailsa Stevens

Two independent studies published in the journal Science this week suggest that many rare gene mutations may be responsible for causing schizophrenia, challenging the widely held theory that combinations of several relatively common mutations are to blame. The researchers found that very rare genetic disruptions, often unique...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

Gene variant linked to increased schizophrenia risk

by Dr Jess Buxton

UK researchers have identified a genetic variation associated with an increased risk of schizophrenia in people with a strong family history of the condition. The team, based at Edinburgh University, discovered that individuals who inherit a particular version of the neuregulin (NRG1) gene have nearly three...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

Study confirms schizophrenia gene link

by BioNews

A new study provides more evidence that a gene which affects levels of a key brain chemical is involved in schizophrenia. A team based at Stanford University in California, US, found that children with a single, 'low-activity' copy of a gene called COMT are at higher risk of developing psychotic...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 1 minute read

Another gene clue to mental illness

by BioNews

Scottish researchers have identified another gene involved in schizophrenia and bipolar disorder (manic depression), a discovery that could lead to new drug treatments for the conditions. The team, based at the Universities of Edinburgh and Glasgow, has shown that an altered version of a gene called PDE4B is linked to...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 2 minutes read

Gene affects risk of depression

by BioNews

How well people cope with stressful experiences such as divorce or unemployment is partly down to variations in a single gene, according to a new study by researchers based in the UK, US and New Zealand. The scientists, who published their findings in last week's Science, found that different versions...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 June 2009 • 1 minute read

Schizophrenia gene link

by BioNews

Scientists from the US National Institute of Mental Health (NIMH) have found a gene variation that may increase the risk of developing schizophrenia. The gene, called COMT (catecho-o-methytransferase) appears to control levels of the chemical dopamine in the brain. Lower levels of dopamine can affect performance in memory tasks and...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Washington state delays vote on stem cell research

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

4 July 2022 • 2 minutes read

Genetic and epigenetic causes of IVF embryo arrest discovered

4 July 2022 • 2 minutes read

Dutch donor-conceived people seek answers

4 July 2022 • 2 minutes read

Genetic variant increases Alzheimer's risk, especially in women

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856